Impaired Long-Term Potentiation in the Prefrontal Cortex of Huntington’s Disease Mouse Models: Rescue by D1 Dopamine Receptor Activation

Publisher： Karger

E-ISSN： 1660-2862|8|4|230-239

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.8, Iss.4, 2011-02, pp. : 230-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impaired Brain Creatine Kinase Activity in Huntington’s Disease

By  

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2010-12 ,pp. : 194-201

Karger

Access to resources Recommend Favorite

Truncated Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α Splice Variant Is Severely Altered in Huntington’s Disease

By  

Neurodegenerative Diseases, Vol. 8, Iss. 6, 2011-07 ,pp. : 496-503

Karger

Access to resources Recommend Favorite

Huntington’s Disease – New Perspectives Based on Neuroendocrine Changes in Rodent Models

By  

Neurodegenerative Diseases, Vol. 6, Iss. 4, 2009-06 ,pp. : 154-164

Karger

Access to resources Recommend Favorite

Impaired Ideomotor Limb Apraxia in Cortical and Subcortical Dementia: A Comparison of Alzheimer’s and Huntington’s Disease

By  

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2011-01 ,pp. : 208-215

Karger

Access to resources Recommend Favorite

Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of parkinson's disease

By Fifel Karim   Dkhissi-Benyahya Ouria   Cooper Howard M.  

Chronobiology International, Vol. 30, Iss. 6, 2013-07 ,pp. : 741-755

Informa Healthcare

Access to resources Recommend Favorite